[go: up one dir, main page]

DD261153A1 - PROCESS FOR THE PREPARATION OF NEW 2-HETEROARYL-5-ACYLAMINO-THIAZOLENE - Google Patents

PROCESS FOR THE PREPARATION OF NEW 2-HETEROARYL-5-ACYLAMINO-THIAZOLENE Download PDF

Info

Publication number
DD261153A1
DD261153A1 DD30092687A DD30092687A DD261153A1 DD 261153 A1 DD261153 A1 DD 261153A1 DD 30092687 A DD30092687 A DD 30092687A DD 30092687 A DD30092687 A DD 30092687A DD 261153 A1 DD261153 A1 DD 261153A1
Authority
DD
German Democratic Republic
Prior art keywords
heteroaryl
formula
acylating agents
acylaminothiazole
preparation
Prior art date
Application number
DD30092687A
Other languages
German (de)
Inventor
Hans W Modrow
Wilfried Thiel
Roland Mayer
Original Assignee
Bitterfeld Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bitterfeld Chemie filed Critical Bitterfeld Chemie
Priority to DD30092687A priority Critical patent/DD261153A1/en
Publication of DD261153A1 publication Critical patent/DD261153A1/en

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Abstract

Die Erfindung betrifft ein Verfahren zur Herstellung von neuen 2-Heteroaryl-5-acylaminothiazolen, die als optische Aufheller, und Pharmaka interessant sind. Das Ziel der Erfindung, bisher unbekannte 2-Heteroaryl-5-acylaminothiazole der Formel II, in der R Heteroaryl bedeutet, in hoher Ausbeute und Reinheit herzustellen, wurde dadurch geloest, dass Heteroaryl-5-aminothiazole der Formel I in geloester Form mit einem Acylierungsmittel umgesetzt werden. Als Acylierungsmittel eignen sich besonders die Saeureanhydride und Saeurechloride, wobei im letzten Fall eine Hilfsbase zugesetzt wird. Als Loesungsmittel fungieren die den Acylierungsmitteln zugrunde liegenden Saeuren, ueberschuessige Acylierungsmittel selbst sowie aprotische Loesungsmittel, vorzugsweise Acetonitril. Formel IIThe invention relates to a process for the preparation of novel 2-heteroaryl-5-acylaminothiazolen, which are interesting as optical brighteners, and pharmaceuticals. The aim of the invention, hitherto unknown 2-heteroaryl-5-acylaminothiazole of the formula II in which R is heteroaryl to produce in high yield and purity, was solved by heteroaryl-5-aminothiazole of formula I in geloester form with an acylating agent be implemented. Particularly suitable acylating agents are the acid anhydrides and acid chlorides, in which case an auxiliary base is added. The solvents used are the acids underlying the acylating agents, excess acylating agents themselves and aprotic solvents, preferably acetonitrile. Formula II

Description

Ausführungsbeispieleembodiments

Allgemeine Vorschriften:General regulations:

Variante A 5 mmol Aminothiazol werden in einer minimalen Menge Säure, mit der acyliert werden soll (A-i), oder Acetonitril (A2) in der Hitze gelöst, mit5-7,5mmol Säureanhydrid versetzt und 10 min weiter erhitzt. Die Acylderivatefaiien in der Regel schon in der Hitze aus, können aber auch mit Wasser gefällt werden. Sie werden abgesaugt, mit Wasser gewaschen und gegebenenfalls umkristallisiert.Variant A 5 mmol of aminothiazole are dissolved in a minimum amount of acid to be acylated (Ai) or acetonitrile (A 2 ) in the heat, admixed with 5-7.5 mmol of acid anhydride and further heated for 10 minutes. The Acylderivatefaiienen usually already in the heat, but can also be precipitated with water. They are filtered off, washed with water and optionally recrystallized.

Variante B Man löst 5 mmol Aminothiazol in wenig heißem Acetonitril, setzt 5 mmol Pyridinzu, versetzt mit 5-6 mmol Säurechlorid und erhitzt kurz. Man verfährt dann weiter nach Variante A Die Acylverbindungen werden nach beiden Varianten in Ausbeuten >90% erhalten. Beispiele sind in der folgenden Tabelle enthalten.Variant B Dissolve 5 mmol of aminothiazole in a little hot acetonitrile, add 5 mmol of pyridine, add 5-6 mmol of acid chloride and heat briefly. The procedure is then continued according to variant A. The acyl compounds are obtained in both variants in yields> 90%. Examples are included in the following table.

Tabelle: 2-Heteroaryl-5-acylaminothiazoleder'FormelTable: 2-Heteroaryl-5-acylaminothiazole Der'Formel RR ππ IlIl Vai teVai te HH Scamp/Scamp / axisaxis Bei-examples Acylacyl -- 318-32318-32 C / T',"1 VT.-, υ / jjiaj.1 C / T ', " 1 VT.-, υ / jjiaj. 1 11 -COCH3 -COCH 3

-GOCF-GOCF

-CJOC ^H1--CJOC ^ H 1 -

Ä1 Ä 1

H3--145H3--145

316-319 / Chlorbenzen316-319 / chlorobenzene

J>J>

A.A.

314-317 / DM?314-317 / DM?

-'. ρTj- '. ρTj

oW.i.oW.i.

307-309307-309

-COCH-COCH

255-257 / DMP255-257 / DMP

Claims (2)

Patentanspruch:Claim: Verfahren zur Herstellung von neuenProcess for the production of new ones 2-Heteroaryl-5-acylaminothiazolen der Formel2-heteroaryl-5-acylaminothiazoles of the formula •s-• s- (II),(II) in der R = Heteroaryl bedeutet, gekennzeichnet dadurch, daß 2-Heteroaryl-5-aminothiazole der Formelin which R = heteroaryl, characterized in that 2-heteroaryl-5-aminothiazoles of the formula (D,(D, in der R die oben genannte Bedeutung hat, mit einem Acylierungsmittei in einem Lösungsmittel umgesetzt wird.in which R has the abovementioned meaning, is reacted with an acylating agent in a solvent. Anwendungsgebiet der ErfindungField of application of the invention Die Erfindung betrifft ein Verfahren zur Herstellung von neuen 2-Heteroaryl-5-acylaminothiazolen, die als Pharmaka verwendet werden können.The invention relates to a process for the preparation of novel 2-heteroaryl-5-acylaminothiazolen which can be used as pharmaceuticals. Charakteristik des bekannten Standes der TechnikCharacteristic of the known state of the art Bisher sind nur wenige 2-substituierte-5-Aminothiazole bzw. deren Acylderivate bekannt. 2-Heteroaryl-5-acylaminothiazole sind noch unbekannt.So far, only a few 2-substituted-5-aminothiazoles or their acyl derivatives are known. 2-heteroaryl-5-acylaminothiazoles are still unknown. Ziel der ErfindungObject of the invention Ziel der Erfindung ist es, bisher unbekannte 2-Heteroaryl-5-acylaminothiazole zu erschließen.The aim of the invention is to develop hitherto unknown 2-heteroaryl-5-acylaminothiazole. Darlegung des Wesens der ErfindungExplanation of the essence of the invention Aufgabe der Erfindung ist es, neue 2-Heteroaryl-5-acylaminothiazole auf einfache Weise in hoher Ausbeute und Reinheit herzustellen.The object of the invention is to produce new 2-heteroaryl-5-acylaminothiazole in a simple manner in high yield and purity. Erfindungsgemäß wird die Aufgabe dadurch gelöst, daß 2-Heteroaryl-5-aminothiazole der FormelAccording to the invention the object is achieved in that 2-heteroaryl-5-aminothiazole of the formula R -<R - < ^ H^ H in der R = Heteroaryl bedeutet, in gelöster Form mit einem Acylierungsmittei umgesetzt werden und dabei bisher unbekannte 2-Heteroaryl-5-acylaminothiazole der Formelin which R = heteroaryl, be reacted in dissolved form with an Acylierungsmittei and thereby previously unknown 2-heteroaryl-5-acylaminothiazole of the formula NH AcylNH acyl S—irS-ir in der R die oben genannte Bedeutung hat, in hoher Reinheit entstehen.in which R has the abovementioned meaning, arise in high purity. Als Acylierungsmittei eignen sich besonders die Säureanhydride und Säurechloride, wobei im letzten Fall eine Hilfsbase zugesetzt werden muß. Als Lösungsmittel können, die den Acylierungsmitteln zugrunde liegenden Säuren, überschüssige Acylierungsmittei sowie aprotische Lösungsmittel, vorzugsweise Acetonitril, dienen.Particularly suitable acylating agents are the acid anhydrides and acid chlorides, in which case an auxiliary base must be added. Suitable solvents are the acids on which the acylating agents are based, excess acylating agents and aprotic solvents, preferably acetonitrile.
DD30092687A 1987-03-19 1987-03-19 PROCESS FOR THE PREPARATION OF NEW 2-HETEROARYL-5-ACYLAMINO-THIAZOLENE DD261153A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD30092687A DD261153A1 (en) 1987-03-19 1987-03-19 PROCESS FOR THE PREPARATION OF NEW 2-HETEROARYL-5-ACYLAMINO-THIAZOLENE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD30092687A DD261153A1 (en) 1987-03-19 1987-03-19 PROCESS FOR THE PREPARATION OF NEW 2-HETEROARYL-5-ACYLAMINO-THIAZOLENE

Publications (1)

Publication Number Publication Date
DD261153A1 true DD261153A1 (en) 1988-10-19

Family

ID=5587584

Family Applications (1)

Application Number Title Priority Date Filing Date
DD30092687A DD261153A1 (en) 1987-03-19 1987-03-19 PROCESS FOR THE PREPARATION OF NEW 2-HETEROARYL-5-ACYLAMINO-THIAZOLENE

Country Status (1)

Country Link
DD (1) DD261153A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006028269A3 (en) * 2004-09-09 2006-06-29 Astellas Pharma Inc Thiazole derivatives having vap-1 ihibitory activity
WO2012161879A1 (en) * 2011-05-23 2012-11-29 Merck Patent Gmbh Thiazole derivatives
WO2014128465A1 (en) * 2013-02-20 2014-08-28 Cancer Therapeutics Crc Pty Ltd 2-(hetero)aryl-benzimidazole and imidazopyridine derivatives as inhibitors of asparagime emethyl transferase
US10005792B2 (en) 2014-09-03 2018-06-26 Ctxt Pty. Ltd. Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors
US10961256B2 (en) 2016-03-09 2021-03-30 Ctxt Pty Ltd PRMT5 inhibitors

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006028269A3 (en) * 2004-09-09 2006-06-29 Astellas Pharma Inc Thiazole derivatives having vap-1 ihibitory activity
WO2012161879A1 (en) * 2011-05-23 2012-11-29 Merck Patent Gmbh Thiazole derivatives
CN103596938A (en) * 2011-05-23 2014-02-19 默克专利有限公司 Thiazole derivatives
JP2014518885A (en) * 2011-05-23 2014-08-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Thiazole derivative
US9249114B2 (en) 2011-05-23 2016-02-02 Merck Patent Gmbh Thiazole derivatives
CN103596938B (en) * 2011-05-23 2016-12-28 默克专利有限公司 Thiazole
AU2012259335B2 (en) * 2011-05-23 2017-03-16 Merck Patent Gmbh Thiazole derivatives
EA026654B1 (en) * 2011-05-23 2017-05-31 Мерк Патент Гмбх Thiazole derivatives
WO2014128465A1 (en) * 2013-02-20 2014-08-28 Cancer Therapeutics Crc Pty Ltd 2-(hetero)aryl-benzimidazole and imidazopyridine derivatives as inhibitors of asparagime emethyl transferase
US9856252B2 (en) 2013-02-20 2018-01-02 Cancer Therapeutics Crc Pty Ltd 2-(hetero)aryl-benzimidazole and imidazopyridine derivatives as inhibitors of asparagime emethyl transferase
US10005792B2 (en) 2014-09-03 2018-06-26 Ctxt Pty. Ltd. Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors
US10961256B2 (en) 2016-03-09 2021-03-30 Ctxt Pty Ltd PRMT5 inhibitors

Similar Documents

Publication Publication Date Title
DD261153A1 (en) PROCESS FOR THE PREPARATION OF NEW 2-HETEROARYL-5-ACYLAMINO-THIAZOLENE
DE1804691C3 (en) Taurocholenic acid derivatives
DE3308922A1 (en) METHOD FOR PRODUCING FATTY ACID ESTERS OF ASCORBIN ACID
DD236922A5 (en) PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CARNITINE NITRIL CHLORIDE
DE2903891A1 (en) OPTICALLY ACTIVE BENZAMIDE, PROCESS FOR THEIR PRODUCTION AND THEIR APPLICATION
CH635065A5 (en) METHOD FOR SEPARATING MIXTURES FROM 3- AND 4-NITROPHTHALIC ACID.
DE2065384B2 (en) Acid addition salts of orthophosphoric acid and succinic acid with 3-methy Iflavone- 8-carboxylic acid beta-piperidinoethyl ester. Eliminated from: 2059296
DE3235372C2 (en)
DE2520131C3 (en) 1,1-disubstituted octahydro-indolo [2,3-a] quinolizines and processes for their preparation
DE1227893B (en) Process for the preparation of glycyrrhetinic acid derivatives
AT229496B (en) Process for the preparation of the new nicotinic acid ester of dihydroxycodeinone
DE3500029A1 (en) Anthracycline esters
DE900097C (en) Process for the production of hexamethylene-1,6-bis-trimethylammonium bitartrate
DE1928144C3 (en) Process for the preparation of anhydrous 6- (1-aminocycloalkylcarboxamido) -penicillanic acids
AT215421B (en) Process for the preparation of 4- (pyridinecarboxamido or -alkylamido) -1-phenyl-2,3-dimethylpyrazolonen- (5)
AT223330B (en) Process for the preparation of new morphine-bis-pyridinecarboxylic acid esters
AT385991B (en) METHOD FOR PRODUCING VINCAMINE TEPROSILATE
AT228932B (en) Process for the preparation of N-acyl derivatives of 6-aminopenicillanic acid
DE1770840B2 (en) Process for the preparation of pyromellitic acid dumide
DE2559520C3 (en) Ethylene-l ^ -bis-phenyM ^ &#39;- carboxylic acid-bis-N-chloramide and naphthalene-2,6-dicarboxylic acid-bis-N-chloramide and processes for their preparation
DE1943667C3 (en) Process for the preparation of isoxazolylpenicillins
DE1903388C3 (en) Process for the preparation of the sodium salt of ampicillin
DE2402231B2 (en) PROCESS FOR THE PRODUCTION OF 4-ACETAMIDOPHENYL-2-ACETOXYBENZOATE
DE2400608A1 (en) PROCESS FOR MANUFACTURING PYRIMIDE DERIVATIVES
DE3506681A1 (en) Process for the preparation of pyridine-2,3-dicarboxylic acid

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee